Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related decrease in responsiveness to L-DOPA is not due to changes in dopamine receptor mRNAs or G protein mRNAs

M Murata1, Y Aihara, H Yamanouchi

  • 1Department of Neurology, School of Medicine, University of Tokyo, Japan.

Journal of Neural Transmission (Vienna, Austria : 1996)
|January 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute encephalopathy associated with hemolytic uremic syndrome caused by Escherichia coli O157: H7 and rotavirus infection.

European review for medical and pharmacological sciences·2015
Same author

Brain hypothermia therapy for status epilepticus in childhood.

European review for medical and pharmacological sciences·2014
Same author

Partial epilepsy and developmental delay in infant with ring chromosome 14.

Genetic counseling (Geneva, Switzerland)·2013
Same author

[East Japan disaster and the Great Hanshin earthquake].

No to hattatsu = Brain and development·2012
Same author

[Clinical trials of intravenous phenobarbital for the establishment of evidence-based standard treatment for status epilepticus in Japan].

No to hattatsu = Brain and development·2011
Same author

Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal effect of early and delayed cooling.

Archives of disease in childhood·2010

Age does not alter dopamine receptor or G protein mRNA levels in human brains. This suggests other factors, like guanine nucleotide binding, may explain reduced L-DOPA response in Parkinson's patients.

Area of Science:

  • Neuroscience
  • Aging Research
  • Pharmacology

Background:

  • Parkinson's disease is characterized by a decline in dopamine signaling.
  • Reduced responsiveness to L-DOPA, a primary Parkinson's treatment, is observed with aging.
  • The molecular mechanisms underlying this age-related decrease are not fully understood.

Purpose of the Study:

  • To investigate age-related changes in the expression of key components of the dopamine receptor-G protein signaling pathway.
  • To determine if altered mRNA levels of dopamine receptors (D1, D2) or G proteins (Gs, Gi, Go) contribute to diminished L-DOPA responsiveness in aging.

Main Methods:

  • Analysis of mRNA levels of dopamine receptors (D1, D2) and G proteins (Gs, Gi, Go) in post-mortem human brain tissue.
  • Study included 22 control human brains with ages ranging from 50 to 105 years.

Related Experiment Videos

  • Correlational analysis to assess the relationship between age and specific mRNA levels.

    • Main Results:

    • No significant age-related changes were observed in the mRNA levels of dopamine receptors (D1, D2).
    • mRNA levels of G proteins (Gs, Gi, Go) also remained stable across the studied age range.
    • These findings indicate that receptor and G protein expression is not the primary factor affected by aging in this pathway.

    Conclusions:

    • The age-related decline in L-DOPA responsiveness in Parkinson's disease is unlikely due to changes in dopamine receptor or G protein mRNA levels.
    • Alternative mechanisms within the receptor-G protein cascade, potentially involving guanine nucleotide binding or post-translational modifications, may be responsible.
    • Further research is needed to elucidate the specific molecular events contributing to age-associated L-DOPA treatment efficacy reduction.